Preventing acute lung injury from progressing to pulmonary fibrosis by maintaining ERS homeostasis through a multistage targeting nanomicelle-Reference-Cited by-同舟云学术

Preventing acute lung injury from progressing to pulmonary fibrosis by maintaining ERS homeostasis through a multistage targeting nanomicelle

Published:2023-02 Issue: Volume:48 Page:101719
ISSN:1748-0132
Container-title:Nano Today
language:en
Short-container-title:Nano Today

Author:

Luo Lihua,Luo Zhenyu,Zhang Junlei,Liu Xu,Huang Jiaxin,Wang Sijie,Yin Hang,Guo Xuemeng,Hu Yilong,Lu Yichao,Shan Xinyu,Liu Huihui,Shi Yingying,Du Yongzhong,Yang Fuchun,You Jian

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Materials Science,Biomedical Engineering,Bioengineering,Biotechnology

Reference59 articles.

1. Acute respiratory distress syndrome

2. Pathogenesis of Acute Respiratory Distress Syndrome

3. Acute Respiratory Distress Syndrome

4. Macrophages: friend or foe in idiopathic pulmonary fibrosis?

5. Macrophages in Lung Injury, Repair, and Fibrosis

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Redox-sensitive disulfide-bridged self-assembled nanoparticles of dexamethasone with high drug loading for acute lung injury therapy;International Journal of Pharmaceutics;2024-10

2. Prolonged resident nanoparticles effectively treat acute lung injury via the selective upregulation of intracellular hydrogen peroxide;Nano Today;2024-06

3. An esterase-activatable nanoprodrug mitigates severe spinal cord injury via alleviating ferroptosis and reprogramming inflammatory microenvironment;Nano Today;2024-06

4. Pulmonary drug delivery devices and nanosystems as potential treatment strategies for acute respiratory distress syndrome (ARDS);International Journal of Pharmaceutics;2024-05

5. Cell-mediated nanoparticle delivery systems: towards precision nanomedicine;Drug Delivery and Translational Research;2024-04-13